Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer's Disease Diagnosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03520998
What this trial is testing

Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseMild to Moderate Alzheimer Disease
Alkahest, Inc. 47
Large-scale testing (Phase 3)Study completedNCT00566501
What this trial is testing

Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Inc. 915
Not applicableStudy completedNCT00034567
What this trial is testing

Healthy Aging and Memory Study

Who this might be right for
Alzheimer Disease
National Institute on Aging (NIA) 650
Not applicableStudy completedNCT05990114
What this trial is testing

Evaluation of the Structured Caregiver Support Program (SCSP) in Terms of Various Parameters

Who this might be right for
Alzheimer Disease
Akdeniz University 50
Not applicableStudy completedNCT00106899
What this trial is testing

ADNI: Alzheimer's Disease Neuroimaging Initiative

Who this might be right for
Alzheimer's Disease
Alzheimer's Disease Cooperative Study (ADCS) 818
Testing effectiveness (Phase 2)Study completedNCT00948909
What this trial is testing

Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 274
Post-approval studies (Phase 4)Study completedNCT00800709
What this trial is testing

Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shanghai Mental Health Center 26
Post-approval studies (Phase 4)Study completedNCT01354444
What this trial is testing

Trial of Carvedilol in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Johns Hopkins University 29
Not applicableNot Yet RecruitingNCT06825663
What this trial is testing

Marker of Brain Insulin Resistance in AD Prognosis

Who this might be right for
Prognosis Biomarker of ADMild Cognitive ImpairmentBrain Insuline Resistance
Central Hospital, Nancy, France 122
Testing effectiveness (Phase 2)Study completedNCT05189106
What this trial is testing

Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial

Who this might be right for
Amyotrophic Lateral SclerosisAlzheimer DiseaseMild Cognitive Impairment
Massachusetts General Hospital 17
Early research (Phase 1)Study completedNCT02142777
What this trial is testing

S-Equol in Alzheimer's Disease (SEAD) Trial

Who this might be right for
Alzheimer's Disease
Russell Swerdlow, MD 15
Not applicableStudy completedNCT03424200
What this trial is testing

Coaching for Cognition in Alzheimer's (COCOA)

Who this might be right for
Alzheimer DiseaseCognitive Impairment
Hoag Memorial Hospital Presbyterian 54
Testing effectiveness (Phase 2)Ended earlyNCT00500500
What this trial is testing

Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ipsen 40
Not applicableStudy completedNCT03389698
What this trial is testing

Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD

Who this might be right for
Alzheimer Disease
NYU Langone Health 27
Testing effectiveness (Phase 2)Study completedNCT00684944
What this trial is testing

Open Label Study of TRx0014 in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TauRx Therapeutics Ltd 111
Not applicableLooking for participantsNCT06547099
What this trial is testing

Study to Understand Novel Biomarkers in Researching Dementia

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentDementia
Washington University School of Medicine 1,800
Early research (Phase 1)Study completedNCT05681819
What this trial is testing

SHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shanghai Hengrui Pharmaceutical Co., Ltd. 33
Not applicableStudy completedNCT00001972
What this trial is testing

PET Scan of Brain Metabolism in Relation to Age and Disease

Who this might be right for
Alzheimer's DiseaseBrain NeoplasmNiemann Pick Disease
National Institute of Neurological Disorders and Stroke (NINDS) 123
Large-scale testing (Phase 3)Ended earlyNCT05310071
What this trial is testing

Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 1,027
Large-scale testing (Phase 3)Ended earlyNCT06736509
What this trial is testing

An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation, Psychomotor
Axsome Therapeutics, Inc. 139
Next Page